Datasheet | March 4, 2025

MDCK Suspension Platform

Source: Sartorius
Sartorius MDCK Suspension Platform

The MDCK Suspension Cell Line from Sartorius is derived from the ATCC MDCK (NBL-2) CCL-34™ cell line. This cell line has been directly adapted to the Sartorius 4Cell® MDXK CD medium, which is a chemically defined medium free from animal-derived components. Importantly, this adaptation process has been carried out without any genetic modifications, ensuring the cell line remains true to its original characteristics. This monoclonal cell line boasts an extensive and well-documented history, making it a reliable and trusted choice for various research and bioproduction applications.

Access the full datasheet to learn more.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online